copper sulfate has been researched along with bucillamine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eguchi, K; Fukuda, T; Ida, H; Ishimaru, T; Kawakami, A; Nakashima, M; Sakai, M; Shimada, H; Terada, K; Yamashita, I | 1 |
| Akamatsu, T; Matsubara, T; Mizuno, K; Saegusa, Y | 1 |
2 other study(ies) available for copper sulfate and bucillamine
| Article | Year |
|---|---|
Bucillamine inhibits T cell adhesion to human endothelial cells.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Catalase; Cell Adhesion; Cell Communication; Cells, Cultured; Copper; Copper Sulfate; Cysteine; Endothelium, Vascular; Humans; Hydrogen Peroxide; Interferon-gamma; Recombinant Proteins; Superoxide Dismutase; T-Lymphocytes; Umbilical Veins | 1992 |
Inhibition of mitogen-induced response of human peripheral blood mononuclear cells by bucillamine, a new antirheumatic sulfhydryl drug.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cell Division; Copper; Copper Sulfate; Cysteine; DNA; Humans; Hydrogen Peroxide; Leukocytes, Mononuclear; Mitogens; Penicillamine; Phytohemagglutinins | 1994 |